Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
1,652,653
-
Share change
-
+275,095
-
Total reported value
-
$47,012,000
-
Price per share
-
$28.30
-
Number of holders
-
7
-
Value change
-
+$7,825,828
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2017
As of 31 Dec 2017,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,652,653 shares.
The largest 7 holders included
Parametric Portfolio Associates LLC, World Asset Management Inc, Sterling Capital Management LLC, GLENMEDE TRUST CO NA, Hexavest Inc., Geneos Wealth Management Inc., and McIlrath & Eck, LLC.
This page lists
7
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.